0.2094 -0.007 (-3.01%) | 07-26 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 0.3 ![]() |
1-year : | 0.33 |
Resists | First : | 0.25 ![]() |
Second : | 0.28 |
Pivot price | 0.24 ![]() |
|||
Supports | First : | 0.2 ![]() |
Second : | 0.17 ![]() |
MAs | MA(5) : | 0.22 ![]() |
MA(20) : | 0.25 ![]() |
MA(100) : | 0.29 ![]() |
MA(250) : | 0.56 ![]() |
|
MACD | MACD : | -0.1 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 4.2 ![]() |
D(3) : | 7.7 ![]() |
RSI | RSI(14): 32.2 ![]() |
|||
52-week | High : | 3.27 | Low : | 0.2 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ FOXO ] has closed below the lower bollinger band by 1.2%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ FOXO ] is to continue within current trading range. Bollinger Bands are 25% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.22 - 0.22 | 0.22 - 0.22 |
Low: | 0.2 - 0.2 | 0.2 - 0.21 |
Close: | 0.21 - 0.21 | 0.21 - 0.21 |
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.
Thu, 25 Jul 2024
FOXO Technologies Inc. (NYSE:FOXO) Major Shareholder Kr8 Ai Inc. Sells 1,300,000 Shares of Stock - Defense World
Wed, 24 Jul 2024
Foxo Technologies interim CEO sells $325k in shares - Investing.com
Wed, 24 Jul 2024
Foxo Technologies interim CFO sells $325,000 in company stock - Investing.com
Tue, 16 Jul 2024
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements - GlobeNewswire
Tue, 16 Jul 2024
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements - StockTitan
Mon, 01 Jul 2024
Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
AMEX
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Healthcare Information Services
|
|
Shares Out | 0 (M) |
Shares Float | 6 (M) |
Held by Insiders | 2.89e+006 (%) |
Held by Institutions | 46 (%) |
Shares Short | 72 (K) |
Shares Short P.Month | 0 (K) |
EPS | -3.946e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -41 % |
Return on Assets (ttm) | 433.3 % |
Return on Equity (ttm) | -93.5 % |
Qtrly Rev. Growth | 457000 % |
Gross Profit (p.s.) | -41.44 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -17.4 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -15 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | -0.24 |
Dividend | 0 |
Forward Dividend | 243680 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |